PCM
CRSP icon

Palisade Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Palisade Capital Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,550
Closed -$246K – 450
2018
Q3 		$246K Buy
+5,550
New +$246K 0.01% 436